Comparing non-affected mutation carriers with PAH patients within the same family, Hamid et al.81 showed that the expression levels from the wild-type BMPR2 allele impact disease progression, with lower BMPR2 expression levels observed in more affected individuals. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.